SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,333,000 | +148.2% | 46,172 | +382.4% | 0.16% | +144.8% |
| Q3 2019 | $1,343,000 | -27.8% | 9,571 | -27.3% | 0.07% | -21.2% |
| Q3 2018 | $1,860,000 | -24.1% | 13,171 | -16.0% | 0.08% | -15.0% |
| Q2 2018 | $2,452,000 | +16.5% | 15,671 | -53.6% | 0.10% | -6.5% |
| Q3 2017 | $2,105,000 | +6.8% | 33,800 | +25.1% | 0.11% | +62.1% |
| Q2 2015 | $1,971,000 | +215.4% | 27,009 | +58.0% | 0.07% | +187.0% |
| Q4 2014 | $625,000 | – | 17,089 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |